Novartis Raises FullYear Sales and Profit Guidance Amid Strong Operational Momentum USChina Trade Talks Reemerge as Key Focus at APEC Summit Expected Value Approach May Boost Predictive AI Returns Fraud Detection Illustrates Humana Shares Decline as Medicare Advantage Rate Update Disappoints Market Expectations Salesforce Receives Mixed Analyst Reviews Deutsche Bank Maintains Positive Outlook While Citi Adjusts Price Target Bitcoin Beyond Speculation Institutional Adoption Reshapes Cryptos Role in Finance ELV Q1 2026 Earnings Strong Earnings Beat Overshadowed by Stock Decline Corteva Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiency MGPI Q1 2026 Earnings EPS Surges Past Estimates with 30872 Surprise GENI Q1 2026 Earnings EPS Falls Short Yet Stock Surges 583 on Strategic Optimism FOA Q1 2026 Earnings Strong EPS Surprise Amidst Uncertain Revenue Outlook SOS Limited Q3 2018 Earnings Significant EPS Miss Highlights Operational Challenges Aclarion Inc Warrants ACONW Edge Lower as Tight Trading Range Persists at 003 Nuveen Mortgage and Income Fund JLS Edges Higher as YieldSeekers Circle Aramark ARMK Slips 072 as Traders Eye Key Support Zone Simulations Plus SLP Surges 268 as Shares Approach 1569 Resistance Zone Church Dwight CHD Holds Steady with Modest Gains as Defensive Appeal Endures HP Exceeds Estimates on AI PC and Windows 11 Demand Shares Initially Surge QuidelOrtho Q1 2026 Earnings EPS Misses Estimates by Wide Margin Yet Stock Rises abrdn Healthcare Opportunities Fund THQ Gains 087 as Sector Rotates into Defensive Names XPO Q1 2026 Earnings EPS Surges 14 Above Estimates Despite Modest Stock Decline STAA Q1 2026 Earnings EPS Soars Past Estimates Stock Declines Despite Strong Beat VTRS Q1 2026 Earnings Strong EPS Beat of 1517 Surprise Amid Stable Execution Apartment Investment and Management Company AIV Q3 2024 Earnings FFO Miss Raises Questions Amid Portfolio Transition Septerna Inc SEPN Q1 2026 Earnings SmallerthanExpected Loss Drives Positive Market Response Sangoma Technologies Q1 2026 Earnings EPS Miss Weighs on Shares as Losses Widen Cytokinetics CYTK Q1 2026 Earnings Smaller Loss Than Expected as Pipeline Progress Continues